Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The risks of systemic corticosteroid use

R S Lester1, S R Knowles, N H Shear

  • 1Division of Dermatology, Sunnybrook Health Science Centre, University of Toronto, Ontario, Canada.

Dermatologic Clinics
|May 20, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus.

Orphanet journal of rare diseases·2023
Same author

Experiences of Student Circus Arts Performers Undertaking a Shoulder Rehabilitation Program Via Telehealth Consultation During the COVID-19 Pandemic.

Medical problems of performing artists·2021
Same author

Psychological mediators of psychological distress and quality of life in inflammatory bowel disease.

Journal of psychosomatic research·2021
Same author

Bruton tyrosine kinase inhibition warrants further study for pemphigus.

The British journal of dermatology·2021
Same author

Blistering severe cutaneous adverse reactions in children: proposal for paediatric-focused clinical criteria.

The British journal of dermatology·2021
Same author

Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus.

The British journal of dermatology·2021
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Systemic corticosteroids are potent anti-inflammatory drugs but can cause adverse effects. This review discusses managing these side effects and minimizing medical-legal risks for dermatologists treating steroid-responsive disorders.

Area of Science:

  • Dermatology
  • Pharmacology

Background:

  • Systemic corticosteroids possess strong anti-inflammatory and immunosuppressive properties.
  • These drugs are widely used to manage diverse diseases.
  • Their use presents challenges due to potential adverse effects.

Purpose of the Study:

  • To review the adverse effects of systemic corticosteroids.
  • To discuss strategies for minimizing these side effects.
  • To outline methods for reducing medical-legal risks associated with corticosteroid adverse reactions.

Main Methods:

  • Literature review of systemic corticosteroid side effects.
  • Analysis of management strategies for adverse events.
  • Discussion of risk mitigation for medical-legal consequences.

Related Experiment Videos

Main Results:

  • Systemic corticosteroids have a broad range of potential adverse effects.
  • Proactive management strategies can mitigate many side effects.
  • Understanding and documenting potential risks can reduce medical-legal issues.

Conclusions:

  • Effective management of systemic corticosteroid side effects is crucial in dermatology.
  • Minimizing adverse reactions improves patient outcomes and reduces physician liability.
  • A comprehensive approach to corticosteroid therapy balances efficacy with safety.